Global Influenza Virus Rapid Antigen Test Kit Market Growth 2024-2030

Global Influenza Virus Rapid Antigen Test Kit Market Growth 2024-2030

The Influenza Virus Rapid Antigen Test Kit is a diagnostic tool designed for the rapid detection of influenza virus antigens in patient samples. Utilizing specific antibodies, this kit enables healthcare professionals to quickly screen for the presence of influenza virus, aiding in the timely diagnosis and management of influenza infections. This rapid antigen test kit provides a convenient and efficient method for frontline healthcare workers to identify influenza cases, facilitating prompt treatment and containment measures during flu outbreaks.



The global Influenza Virus Rapid Antigen Test Kit market size is projected to grow from US$ 218 million in 2024 to US$ 283 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Influenza Virus Rapid Antigen Test Kit Industry Forecast” looks at past sales and reviews total world Influenza Virus Rapid Antigen Test Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Influenza Virus Rapid Antigen Test Kit sales for 2024 through 2030. With Influenza Virus Rapid Antigen Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Virus Rapid Antigen Test Kit industry.

This Insight Report provides a comprehensive analysis of the global Influenza Virus Rapid Antigen Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Virus Rapid Antigen Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Virus Rapid Antigen Test Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Virus Rapid Antigen Test Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Virus Rapid Antigen Test Kit.

United States market for Influenza Virus Rapid Antigen Test Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Influenza Virus Rapid Antigen Test Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Influenza Virus Rapid Antigen Test Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Influenza Virus Rapid Antigen Test Kit players cover BD, Abbott, Quidel, Roche, Actim, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Virus Rapid Antigen Test Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Conventional RIDT
Digital RIDT

Segmentation by Application:
Hospital
POCT
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Abbott
Quidel
Roche
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene

Key Questions Addressed in this Report

What is the 10-year outlook for the global Influenza Virus Rapid Antigen Test Kit market?

What factors are driving Influenza Virus Rapid Antigen Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Influenza Virus Rapid Antigen Test Kit market opportunities vary by end market size?

How does Influenza Virus Rapid Antigen Test Kit break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.